ID
Integral Derivatives Portfolio holdings
AUM
$4.07B
Turnover
54.59%
1-Year Est. Return
19.81%
This Fund
S&P 500
This Quarter
Est. Return
+13.15%
1 Year Est. Return
+19.81%
3 Year Est. Return
+45.77%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.24B
AUM Growth
–
Cap. Flow
+$922M
Cap. Flow
% of AUM
12.73%
Top 10 Holdings %
Top 10 Hldgs %
35.17%
Holding
1,448
New
1,447
Increased
–
Reduced
–
Closed
–
Avg Time Held Equity + Options
0
years
Top 10 Avg Time Held Equity + Options
0
years
Top 20 Avg Time Held Equity + Options
0
years
Avg Time Held Equity only
0
years
Top 10 Avg Time Held Equity only
0
years
Top 20 Avg Time Held Equity only
0
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$172M |
| 2 |
Procter & Gamble
PG
|
+$85M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$49.2M |
| 4 |
Booking.com
BKNG
|
+$43.7M |
| 5 |
Caterpillar
CAT
|
+$20.2M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 87.18% |
| 2 | Technology | 3.29% |
| 3 | Energy | 2.41% |
| 4 | Consumer Discretionary | 1.52% |
| 5 | Communication Services | 1.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1276
Boyd Gaming
BYD
$5.01B
| $249K | ﹤0.01% |
+22,105
| New | +$261K |
2013 Q4
0 quarters
|
|
|
1277
PUT
Boyd Gaming
BYD
$5.01B
| $249K | ﹤0.01% |
+22,100
| New | +$261K |
2013 Q4
0 quarters
|
|
1278
CALL
United Therapeutics
UTHR
$23.3B
| $249K | ﹤0.01% |
+2,200
| New | +$198K |
2013 Q4
0 quarters
|
|
1279
PUT
iShares MSCI EAFE ETF
EFA
$76.3B
| $248K | ﹤0.01% |
+3,700
| New | +$242K |
2013 Q4
0 quarters
|
|
1280
CALL
Gogo Inc
GOGO
$281M
| $248K | ﹤0.01% |
+10,000
| New | +$231K |
2013 Q4
0 quarters
|
|
|
1281
PUT
Gogo Inc
GOGO
$281M
| $248K | ﹤0.01% |
+10,000
| New | +$231K |
2013 Q4
0 quarters
|
|
1282
PUT
Intrepid Potash
IPI
$434M
| $247K | ﹤0.01% |
+1,560
| New | +$242K |
2013 Q4
0 quarters
|
|
|
KERX
1283
CALL
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $247K | ﹤0.01% |
+19,100
| New | +$228K |
2013 Q4
0 quarters
|
|
1284
Jones Lang LaSalle
JLL
$13.4B
| $246K | ﹤0.01% |
+2,400
| New | +$225K |
2013 Q4
0 quarters
|
|
1285
PUT
DELISTED
Newfield Exploration
NFX
| $246K | ﹤0.01% |
+10,000
| New | +$281K |
2013 Q4
0 quarters
|
|
|
FIO
1286
DELISTED
FUSION-IO INC COM
FIO
| $246K | ﹤0.01% |
+27,641
| New | +$299K |
2013 Q4
0 quarters
|
|
1287
CALL
Suncor Energy
SU
$88.7B
| $245K | ﹤0.01% |
+7,000
| New | +$246K |
2013 Q4
0 quarters
|
|
1288
PUT
Vertex Pharmaceuticals
VRTX
$126B
| $245K | ﹤0.01% |
+3,300
| New | +$230K |
2013 Q4
0 quarters
|
|
1289
Opko Health
OPK
$1B
| $244K | ﹤0.01% |
+28,965
| New | +$293K |
2013 Q4
0 quarters
|
|
1290
CALL
Community Health Systems
CYH
$420M
| $243K | ﹤0.01% |
+7,502
| New | +$258K |
2013 Q4
0 quarters
|
|
|
ENDP
1291
CALL
DELISTED
Endo International plc
ENDP
| $243K | ﹤0.01% |
+3,600
| New | +$205K |
2013 Q4
0 quarters
|
|
|
MDR
1292
DELISTED
McDermott International
MDR
| $243K | ﹤0.01% |
+8,826
| New | +$207K |
2013 Q4
0 quarters
|
|
1293
PUT
Arcos Dorados Holdings
ARCO
$1.66B
| $242K | ﹤0.01% |
+20,556
| New | +$236K |
2013 Q4
0 quarters
|
|
1294
PUT
Assured Guaranty
AGO
$3.04B
| $241K | ﹤0.01% |
+10,200
| New | +$222K |
2013 Q4
0 quarters
|
|
|
GWR
1295
DELISTED
Genesee & Wyoming Inc.
GWR
| $240K | ﹤0.01% |
+2,500
| New | +$241K |
2013 Q4
0 quarters
|
|
|
HSH
1296
DELISTED
HILLSHIRE BRANDS CO
HSH
| $240K | ﹤0.01% |
+7,170
| New | +$233K |
2013 Q4
0 quarters
|
|
|
VPHM
1297
PUT
DELISTED
VIROPHARMA INC
VPHM
| $239K | ﹤0.01% |
+4,800
| New | +$215K |
2013 Q4
0 quarters
|
|
1298
Quest Diagnostics
DGX
$25.9B
| $237K | ﹤0.01% |
+4,423
| New | +$262K |
2013 Q4
0 quarters
|
|
1299
WisdomTree
WT
$3.18B
| $237K | ﹤0.01% |
+13,400
| New | +$191K |
2013 Q4
0 quarters
|
|
|
CY
1300
CALL
DELISTED
Cypress Semiconductor
CY
| $236K | ﹤0.01% |
+22,500
| New | +$213K |
2013 Q4
0 quarters
|
|
Similar funds
EIM
DIA
CAM
VAM
SI
PJC
SWITC
SMA
Integral Derivatives's Q4 2013 Portfolio in Review
Q4 2013 is the first quarter with a 13F filing on record for Integral Derivatives, which disclosed 1,448 positions worth $7.24B. Its ten largest holdings account for 35% of the portfolio.
Its largest position is Apple: 9,092,020 shares worth $182M.
By sector, the portfolio is most concentrated in Miscellaneous at 87% of assets, followed by Technology and Energy.
- Integral Derivatives's largest Q4 2013 buy was Apple: 9,092,020 shares worth $182M.
- Integral Derivatives's ten largest holdings make up 35% of its $7.24B portfolio in Q4 2013.
- Integral Derivatives disclosed 1,448 positions in Q4 2013, its first 13F filing on record.
Based on Integral Derivatives's 13F filing for Q4 2013, filed 12 Feb 2014.